Daniel Kavanagh, PhD, RAC
Senior Scientific Advisory, Gene Therapy, Vaccines and Biologics, WCG
Biography
Daniel Kavanagh, PhD, RAC, is the senior scientific advisor of gene therapy, vaccines, and biologics at WCG. Prior to joining WCG, he was assistant professor of medicine and Institutional Biosafety Committee vice chair at Harvard Medical School, and assistant immunologist at the Massachusetts General Hospital. He was also co-chair of a Phase 1 clinical trial of a therapeutic mRNA vaccine. He is certified in US Regulatory Affairs (RAC) by the Regulatory Affairs Professional Society.
Latest insights by Daniel
NIH Launches NExTRAC to Advise on Emerging Biotechnologies
Blog Posts
Amendments to the NIH Guidelines: Effects on Human Gene Transfer Research
Blog Posts
Germline Modification for HIV Prevention is Unjustified
Blog Posts
Changes to Human Gene Transfer Oversight at NIH
Blog Posts
Clinical Trial Safety
Infectious Disease Challenge Studies: Ethical Issues in Causing Disease for Medical Knowledge
Whitepapers
Cell & Gene Therapy
Ethical and Biosafety Oversight of Gene Transfer Clinical Research: What Sponsors and CROs Need to Know
Whitepapers